Cleared Traditional

K161625 - PixelShine

K161625 is an FDA 510(k) clearance for PixelShine, manufactured by Algomedica. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 98-day FDA review.

K161625 · Algomedica · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2016
Decision
98d
Days
Class 2
Risk

K161625 is an FDA 510(k) clearance for the PixelShine. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Algomedica (Palo Alto, US). The FDA issued a Cleared decision on September 19, 2016 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K161625

510(k) Number K161625 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 13, 2016
Decision Date September 19, 2016
Days to Decision 98 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d faster than avg
Panel avg: 107d · This submission: 98d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Devine Guidance International, Inc.
Christopher J. Devine

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2233
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K161625.
kneeEOS
K161828 · Onefit Medical · Oct 2016
CAAS MRV
K162112 · Pie Medical Imaging BV · Sep 2016
Scenium
K162339 · Siemens Medical Solutions USA, Inc. · Sep 2016
JiveX
K162008 · Visus Technology Transfer GmbH · Sep 2016
PROcedure Rehearsal Studio
K153705 · 3Dsystems, Simbionix Products · Sep 2016
Restore PACS
K162141 · Xian Wingspan Electronic Technology Co., Ltd. · Sep 2016